[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
Hepatocellular carcinoma mechanisms associated with chronic HCV infection and the impact of direct-acting antiviral treatment
S Dash, Y Aydin, KE Widmer… - Journal of hepatocellular …, 2020 - Taylor & Francis
Hepatitis C virus (HCV) infection is the major risk factor for liver cirrhosis and hepatocellular
carcinoma (HCC). The mechanisms of HCC initiation, growth, and metastasis appear to be …
carcinoma (HCC). The mechanisms of HCC initiation, growth, and metastasis appear to be …
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
F Conti, F Buonfiglioli, A Scuteri, C Crespi, L Bolondi… - Journal of …, 2016 - Elsevier
Background & Aims Hepatocellular carcinoma (HCC) represents a serious complication of
HCV-related cirrhosis. New direct-acting antivirals (DAA) cure HCV infection in over 90% of …
HCV-related cirrhosis. New direct-acting antivirals (DAA) cure HCV infection in over 90% of …
Changing trends in etiology‐based and ethnicity‐based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States
With recent improvements in the treatment of end‐stage liver disease (ESLD), a better
understanding of the burden of cirrhosis and hepatocellular carcinoma (HCC) is needed in …
understanding of the burden of cirrhosis and hepatocellular carcinoma (HCC) is needed in …
Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study
Background & Aims Direct-acting antiviral agents (DAAs) are safe and effective in patients
with hepatitis C. Conflicting data were reported on the risk of hepatocellular carcinoma …
with hepatitis C. Conflicting data were reported on the risk of hepatocellular carcinoma …
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals
S Perez, A Kaspi, T Domovitz, A Davidovich… - PLoS …, 2019 - journals.plos.org
The increasing worldwide prevalence of Hepatocellular carcinoma (HCC), characterized by
resistance to conventional chemotherapy, poor prognosis and eventually mortality, place it …
resistance to conventional chemotherapy, poor prognosis and eventually mortality, place it …
Nonreversible MAIT cell‐dysfunction in chronic hepatitis C virus infection despite successful interferon‐free therapy
J Hengst, B Strunz, K Deterding… - European journal of …, 2016 - Wiley Online Library
Immune exhaustion is a hallmark of chronic viral infections. However, pathogen eradication
can result in reinvigorated immune responses. Indeed, this was recently suggested for …
can result in reinvigorated immune responses. Indeed, this was recently suggested for …
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
Hepatitis C virus infection is a major cause of hepatocellular carcinoma worldwide.
Interferon has been the major antiviral treatment, yielding viral clearance in approximately …
Interferon has been the major antiviral treatment, yielding viral clearance in approximately …
2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
Risk of hepatocellular carcinoma after HCV clearance by direct-acting antivirals treatment predictive factors and role of epigenetics
Direct-acting antivirals (DAAs) induce a rapid virologic response (SVR) in up to 99% of
chronic hepatitis C patients. The role of SVR by DAAs on the incidence or recurrence of …
chronic hepatitis C patients. The role of SVR by DAAs on the incidence or recurrence of …